Page last updated: 2024-12-05

2-ethylhexyl acrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Ethylhexyl acrylate (2-EHA) is a colorless liquid monomer that is commonly used in the production of polymers and copolymers. It is synthesized through the esterification of acrylic acid with 2-ethylhexanol. 2-EHA is a versatile monomer with good adhesion, flexibility, and water resistance properties. These characteristics make it a popular choice for applications such as paints, coatings, adhesives, and sealants. Furthermore, 2-EHA is known for its low volatility and high viscosity, which contribute to its desirable properties in various industrial applications. Due to its widespread usage, the study of 2-EHA is important to assess its potential environmental impact, evaluate its health effects, and develop more sustainable alternatives. Researchers investigate its potential for biodegradation, its toxicity to aquatic organisms, and its effects on human health. '

Cross-References

ID SourceID
PubMed CID7636
CHEMBL ID1574328
CHEBI ID82465
SCHEMBL ID14869
MeSH IDM0111669

Synonyms (75)

Synonym
9003-77-4
LS-14013
2-ethylhexyl acrylate
2-ethylhexyl 2-propenoate
103-11-7
2-propenoic acid, 2-ethylhexyl ester
wln: 4y2 & 1ov1u1
acrylic acid, 2-ethylhexyl ester
1-hexanol, acrylate
nsc4803
nsc-4803
2-ethyl-1-hexyl acrylate
2-ethylhexylester kyseliny akrylove [czech]
brn 1765828
ccris 3430
ai3-03833
1-hexanol, 2-ethyl-, acrylate
mono(2-ethylhexyl) acrylate
einecs 203-080-7
nsc 4803
hsdb 1121
einecs 215-330-2
NCGC00091115-01
2-ethylhexyl acrylate, 98%, contains >=0.001-<=0.11% monomethyl ether hydroquinone as stabilizer
NCGC00091115-02
2eha
2-ethylhexyl acrylate monomer
octyl acrylate monomer
acrylic acid 2-ethylhexyl ester monomer
A0144
acrylic acid octyl ester monomer
2-ethylhexyl prop-2-enoate
NCGC00091115-03
C19420
tox21_303227
NCGC00256960-01
cas-103-11-7
dtxcid405297
dtxsid9025297 ,
tox21_202053
NCGC00259602-01
2-ethylhexylacrylate
2-ethylexyl acrylate
unii-hr49r9s6xg
ec 203-080-7
2-ethylhexylester kyseliny akrylove
hr49r9s6xg ,
FT-0612226
AKOS015894409
ethylhexyl acrylate [inci]
jc base acrylate
ethylhexylacrylate
norsocryl 2-eha
2-ethylhexyl acrylate [iarc]
SCHEMBL14869
CHEBI:82465 ,
acrylic acid 2-ethylhexyl ester
CHEMBL1574328
Q-200277
2-ethylhexyl ester of acrylic acid
2-ethylhexanol acrylate
2eha; eha; jr 910; nsc 4803; norsocryl 2-eha
mfcd00009495
2-ethylhexyl acrylate, analytical standard
2-ethylhexyl acrylate monomer (stabilized with mehq)
2-ethylhexyl acrylate monomer, stab. w/mehq
acrylic acid-2-ethylhexyl ester
Q209383
mfcd00084372
2-ethylhexyl acrylate resin
2-ethylhexyl propenoate
A896619
2-ethylhexyl acrylate (iarc)
2-ethylhexyl-2-propenoate
(+/-)-acrylic acid 2-ethylhexyl ester

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" In combination with the analysis of the extractables of the UV-cured networks (polymers not attached to the network, impurities that originate from the photo-initiator and unreacted monomers), more insight in the total network structure was obtained."( Characterisation of UV-cured acrylate networks by means of hydrolysis followed by aqueous size-exclusion combined with reversed-phase chromatography.
de Koster, CG; Dias, AA; Litvinov, VM; Mengerink, Y; Peters, R; Schoenmakers, P; Steeman, P; van Benthem, R; van der Wal, S, 2007
)
0.34

Dosage Studied

ExcerptRelevanceReference
" Dermal carcinogenicity studies performed with 2-EHA are reviewed, contrasting the results in two mouse strains (C3H/HeJ and NMRI) under different dosing regimens."( Critical evaluation of 2-ethylhexyl acrylate dermal carcinogenicity studies using contemporary criteria.
Ellis-Hutchings, R; Finch, L; Murphy, S; Welz, S; Wiench, K, 2018
)
0.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency43.25730.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency15.30850.000221.22318,912.5098AID1259247
thyroid stimulating hormone receptorHomo sapiens (human)Potency2.51190.001318.074339.8107AID926; AID938
progesterone receptorHomo sapiens (human)Potency68.58960.000417.946075.1148AID1346784
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency34.23200.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency48.55770.001530.607315,848.9004AID1259401
estrogen nuclear receptor alphaHomo sapiens (human)Potency51.48290.000229.305416,493.5996AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency8.68310.001024.504861.6448AID743215
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency30.63790.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (26.67)18.7374
1990's8 (26.67)18.2507
2000's5 (16.67)29.6817
2010's8 (26.67)24.3611
2020's1 (3.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.64 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index89.01 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.33%)5.53%
Reviews2 (6.67%)6.00%
Case Studies2 (6.67%)4.05%
Observational0 (0.00%)0.25%
Other25 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]